Literature DB >> 6327750

The corticotropin-releasing hormone stimulation test: a possible aid in the evaluation of patients with adrenal insufficiency.

H M Schulte, G P Chrousos, P Avgerinos, E H Oldfield, P W Gold, G B Cutler, D L Loriaux.   

Abstract

Ten patients with adrenal insufficiency receiving chronic glucocorticoid therapy were studied. All had subnormal plasma cortisol responses to ovine corticotropin-releasing hormone ( CRH ) (1 microgram/kg as an iv bolus) 12-60 h after discontinuation of steroid treatment. Plasma ACTH responses to CRH fell into three different patterns. The first three patients with primary adrenal insufficiency had high basal ACTH levels and augmented ACTH responses to CRH . A fourth such patient, however, treated with pharmacologic doses of prednisone, had a low normal ACTH response. Patients with secondary adrenal insufficiency had either low basal ACTH levels and diminished responses to CRH or low basal ACTH values but prolonged and augmented plasma ACTH responses to CRH with a delayed peak. We postulate that the group of patients with the former pattern have pituitary gland destruction whereas the patients with the latter pattern have hypothalamic CRH deficiency. Thus, CRH may be useful in differentiating between hypothalamic and pituitary causes of adrenal insufficiency.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6327750     DOI: 10.1210/jcem-58-6-1064

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  14 in total

1.  The silent corticotropinoma: is clinical diagnosis possible?

Authors:  B Ambrosi; P Colombo; D Bochicchio; M Bassetti; B Masini; G Faglia
Journal:  J Endocrinol Invest       Date:  1992-06       Impact factor: 4.256

2.  Coexistence of hypothalamic and pituitary failure after successful pituitary surgery in Cushing's disease?

Authors:  A R Hermus; G F Pieters; G J Pesman; E Meijer; A G Smals; T J Benraad; P W Kloppenborg
Journal:  J Endocrinol Invest       Date:  1987-08       Impact factor: 4.256

3.  Stimulation of the hypothalamic-pituitary-adrenal axis with the opioid antagonist nalmefene.

Authors:  Eliza B Geer; Rita E Landman; Sharon L Wardlaw; Irene M Conwell; Pamela U Freda
Journal:  Pituitary       Date:  2005       Impact factor: 4.107

4.  Assessment of hypothalamic-pituitary-adrenal (HPA) axis dysfunction: comparison of ACTH stimulation, insulin-hypoglycemia and metyrapone.

Authors:  P I Hartzband; A J Van Herle; L Sorger; D Cope
Journal:  J Endocrinol Invest       Date:  1988-12       Impact factor: 4.256

5.  Corticotropin-releasing hormone links pituitary adrenocorticotropin gene expression and release during adrenal insufficiency.

Authors:  L J Muglia; L Jacobson; C Luedke; S K Vogt; M L Schaefer; P Dikkes; S Fukuda; Y Sakai; T Suda; J A Majzoub
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

Review 6.  Physiological basis for the etiology, diagnosis, and treatment of adrenal disorders: Cushing's syndrome, adrenal insufficiency, and congenital adrenal hyperplasia.

Authors:  Hershel Raff; Susmeeta T Sharma; Lynnette K Nieman
Journal:  Compr Physiol       Date:  2014-04       Impact factor: 9.090

7.  The influence of human corticotropin-releasing hormone on somatostatin secretion in depressed patients and controls.

Authors:  K P Lesch; E Widerlöv; R Ekman; G Laux; R Rupprecht; H M Schulte; H Beckmann
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

8.  Comparison of insulin hypoglycemia and short metyrapone tests in patients with pituitary disease.

Authors:  K Achenbach; W Oelkers
Journal:  Klin Wochenschr       Date:  1985-08-16

9.  Ranitidine treatment and cortisol metabolism in man.

Authors:  H Mönig; K Hoffmann; E E Ohnhaus; H M Schulte
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1992 Jan-Mar       Impact factor: 2.441

10.  Human corticotropin-releasing factor plus lysine vasopressin test during glucocorticoid therapy.

Authors:  K Hashimoto; S Suemaru; T Takao; M Sugawara; T Hattori; J Kageyama; K Takahashi; Z Ota
Journal:  J Clin Invest       Date:  1988-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.